Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesBlood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study
Vascular Health and Risk Management, 08/31/09
Barrios V et al. – Olmesartan 40 mg/day and olmesartan 20 mg/day plus HCTZ 12.5 mg/day allow substantial proportions of patients to achieve BP goals.
Related Articles
Benefits of the angiotensin II receptor antagonist olmesartan in controlling hypertension and cerebral hemodynamics after stroke
Hypertension Research, 11/11/09
Relevance Score: 87%
Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension
Hypertension Research, 11/10/09
Relevance Score: 84%
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 11/10/09
Relevance Score: 80%
Angiotensin II receptor blocker attenuates PDGF-induced mesangial cell migration in a receptor-independent manner
Nephrology Dialysis Transplantation, 10/08/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injury
Atherosclerosis, 12/04/09
Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD: a systematic review and meta-analysis
European Respiratory Journal , 12/03/09
The Cost Effectiveness and Cost Utility of Valsartan in Chronic Heart Failure Therapy in Italy: A Probabilistic Markov Model
American Journal of Cardiovascular Drugs, 12/03/09
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Impacts of Changes in Obesity Parameters for the Prediction of Blood Pressure Change in Japanese Individuals
Kidney and Blood Pressure Research, 12/03/09
O-GlcNAcylation Contributes to Augmented Vascular Reactivity Induced by Endothelin
Hypertension, 12/03/09
P-Wave Dispersion and Its Relationship to Aortic Elasticity in Young Prehypertensive Patients
American Journal of Hypertension, 12/01/09
Sponsor
Article Search
Sponsor
Sponsor